COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

• 收藏
• 分享

专利权人:

INC.;EMORY UNIVERSITY;PRESIDENT AND FELLOWS OF HARVARD COLLEGE;DANA-FARBER CANCER INSTITUTE;DANA-FARBER CANCER INSTITUTE, INC.

发明人:

SHARPE, ARLENE,FREEMAN, GORDON,AHMED, RAFI,AMARA, RAMA

申请号：

NZ59623707

公开号：

NZ596237A

申请日:

2007.12.26

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

The use of a Programmed Death (PD-1) antagonist and a viral antigen for treating a mammalian subject having a chronic hepatitis C viral infection. The antagonist can be an anti-PD1 antibody, an anti-Programmed Death Ligand 1 (PD-L1) or an anti-PD-L2 antibody； a siRNA or antisense RNA directed to PD-1, PD-L1 or PD-L2； or a dominant negative PD-1, PD-L1 or PD-L2 protein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/